According to MedPage Today, dozens of Americans have sued manufacturers of GLP-1 receptor agonists, claiming the companies did not adequately warn about the risk of non-arteritic anterior ischemic optic neuropathy (NAION). NAION is a condition that can lead to sudden vision loss. The lawsuits argue that patients were not given enough information to weigh this potential danger.
The legal claims focus on the absence or insufficiency of warnings on drug labels and in patient materials. The plaintiffs allege that better warnings could have changed their decisions about using the medications. As of the report, the drugmakers have not publicly responded, and the cases remain unresolved.